Stock Price Quote

KOPRAN LTD.

NSE : KOPRANBSE : 524280ISIN CODE : INE082A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE266.50-0.4 (-0.15 %)
PREV CLOSE ( ) 266.90
OPEN PRICE ( ) 261.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22951
TODAY'S LOW / HIGH ( )261.60 273.20
52 WK LOW / HIGH ( )140 292.4
NSE266.25-0.7 (-0.26 %)
PREV CLOSE( ) 266.95
OPEN PRICE ( ) 265.60
BID PRICE (QTY) 266.25 (93)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 265508
TODAY'S LOW / HIGH( ) 263.20 273.10
52 WK LOW / HIGH ( )140 292.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1958
Management Info
Susheel G Somani - Chairman - Managing Director
Registered Office

Address Parijat House,1076 Dr E Moses Road,Worli,
Mumbai,
Maharashtra-400018

Phone 022- 43661111

Email investors@kopran.com

Website www.kopran.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE, MCX

NEWS

08Apr Clarification Letter For The AGM Anno
Clarification Letter for the AGM proceedings held on September 14, 2023..
19Mar Kopran informs about details of loss o
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disc..
17Jan Kopran informs about loss of share cer
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disc..
21Nov Kopran informs about issue of duplicat
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disc..
17Nov Kopran informs about loss of share cer
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disc..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit85.1312.52
Gross Profit 111.57 369.15
Operating Profit 133.54439.99
Net Sales 823.342730.95

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2542.60 (12.29%)
M.Cap ( in Cr)1556.89
Neuland Laboratories (BSE)
peergroup  7654.80 (1.79%)
M.Cap ( in Cr)9842.71
Mankind Pharma (BSE)
peergroup  2397.40 (5.05%)
M.Cap ( in Cr)95740.64
Sanofi India (BSE)
peergroup  8470.70 (0.89%)
M.Cap ( in Cr)19557.14
Solara Active Pharma (BSE)
peergroup  474.10 (12.15%)
M.Cap ( in Cr)1708.74

Shareholding Pattern

NON-INSTITUTION 53.47%
PROMOTERS 44.49%
MUTUAL FUNDS/UTI 0.94%
FI/BANKS/INSURANCE 0.14%
GOVERNMENT 0%
FII 0%

About Kopran Ltd.

Kopran Ltd. was incorporated in the year 1958. Its today's share price is 266.5. Its current market capitalisation stands at Rs 1280.23 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2731.78 Cr and Total Income of Rs.2891.81 Cr. The company's management includes Sunil Sodhani, Varun Somani, Sunita Banerji, Siddhan Subramanian, Narayan Atal, Mamta Biyani, Adarsh Somani, Surendra Somani, Susheel G Somani.

It is listed on the BSE with a BSE Code of 524280 , NSE with an NSE Symbol of KOPRAN and ISIN of INE082A01010. It's Registered office is at Parijat House,1076 Dr E Moses Road,WorliMumbai-400018, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Batliboi & Purohit, Khandelwal Jain & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.